Abstract
The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.
Original language | English |
---|---|
Pages (from-to) | 1-2 |
Number of pages | 2 |
Journal | Nature Reviews Gastroenterology and Hepatology |
DOIs | |
Publication status | Accepted/In press - 2018 Apr 30 |
ASJC Scopus subject areas
- Hepatology
- Gastroenterology